Clinical Trial Update: Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for carfilzomib in relapsed multiple myeloma. The Phase 2 study is completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)

Snippet

Sponsor: Amgen | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2015-12-03